Skip to content

Over 40% of HIV-infected gay men in UK unaware of status; more than half believe they are HIV-negative

Botswana’s adult HIV mortality rate falls since the rollout of free antiretroviral therapy

HIV/HCV coinfected patients more prone to end-stage liver disease without treatment

Is Uganda's HIV prevention success story 'unravelling'?

The limits of PEP: saturation knowledge does not mean saturation use

MK-0518 integrase inhibitor effective in treatment-naive patients

TNX-355, new entry inhibitor, effective in highly treatment-experienced patients

Maraviroc raises CD4 counts in patients with mixed-tropism virus, may offer value for highly treatment-experienced

Kaletra monotherapy as effective as triple therapy for at least 18 months